See every side of every news story
Published loading...Updated

Blood test for ovarian cancer misses some Black and Native American patients, study finds

  • A new study finds that the CA-125 blood test for ovarian cancer may miss diagnoses in Black and Native American patients, delaying treatment.
  • Black and Native American patients were 23% less likely to have elevated CA-125 levels compared to white patients, suggesting current thresholds are too high.
  • Patients with false negative results started chemotherapy nine days later than those with elevated levels, indicating delayed treatment.
  • New thresholds for the blood test are proposed to ensure faster care for all patients when ovarian cancer is suspected.
Insights by Ground AI
Does this summary seem wrong?

83 Articles

All
Left
14
Center
22
Right
17
Tioga PublishingTioga Publishing
+23 Reposted by 23 other sources
Center

Ovarian Cancer Test May Miss Black and Native American Patients

Key Takeaways

·Pennsylvania, United States
Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 42% of the sources are Center
42% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Medical Xpress broke the news in on Thursday, March 20, 2025.
Sources are mostly out of (0)

You have read out of your 5 free daily articles.

Join us as a member to unlock exclusive access to diverse content.